摘要
目的分析苯磺酸氨氯地平与替米沙坦或吲达帕胺联用,治疗高血压合并左室肥厚(LVH)患者的临床疗效。方法选择我院高血压合并LVH的患者126例,分为研究组63例、对照组63例。对照组采取苯磺酸氨氯地平和替米沙坦联合治疗,研究组采取吲达帕胺和苯磺酸氨氯地平联合治疗。对比两组的临床疗效,并发症等。结果研究组患者总有效率93.7%,高于对照组(76.2%);研究组患者并发症发生率7.9%,低于对照组(17.5%)。两组数据对比,差异均有统计学意义(P<0.05)。结论在高血压合并LVH患者的临床治疗中,采取苯磺酸氨氯地平联合吲达帕胺治疗,能够有效控制高血压,改善左心室肥厚情况,减少患者并发症。
Objective To analyze the clinical effect of amlodipine combined with telmisartan or indapamide in the treatment of patients with hypertension and left ventricular hypertrophy (LVH).Methods 126 cases of patients with hypertension and LVH in our hospital were divided into study group and control group, 63 cases in each group. The control group was treated with amlodipine and telmisartan, study group was treated with indapamide and amlodipine. Compared the clinical effcacy, complications between two groups. ResultsThe total effective rate of the study group was 93.7%, which was signiifcantly higher than that of the control group (76.2%). The complication rate of the study group was 7.9%, which was significantly lower than that of the control group (17.5%) (P〈0.05). Conclusion Indapamide and amlodipine besylate in the treatment of patients with hypertension and LVH, can effectively control hypertension and left ventricular hypertrophy, to reduce the complications.
出处
《中国继续医学教育》
2016年第32期180-181,共2页
China Continuing Medical Education